Company intelligence / Profile preview

Specifica

Santa Fe, New Mexico, United Statesspecifica.bio ↗

Ownership: Private
Development stage: Commercial

Overview

Specifica has developed a patented Generation 3 Antibody Library Discovery Platform that yields drug-like antibodies directly from selections, minimizing the need for downstream engineering. Their libraries are highly diverse and developable, with over 80% of selected antibodies showing no measurable biophysical liabilities. The company offers exclusive library creation, custom library design, full technology transfer to partners, and advanced informatics through AbXtractTM. They do not appear to have their own clinical pipeline but enable discovery programs at partner organizations.

Therapeutic areas: Other
Modalities: Monoclonal antibodyAntibody fragment (Fab)Single-chain variable fragment (scFv)Nanobody therapy (VHH format)
Industry: Drug Discovery Services

Partnerships

Not specifically listed by name in available sources; collaborates with biotech/pharma companies on custom libraries and discovery campaigns

Beyond the preview

Go deeper on Specifica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Specifica.

Explore the full profile